Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations

Valerie Waters^{1

2

3}

Affiliations

¹ Research Institute The Hospital for Sick Children Toronto, Ontario, Canada.
² Department of Pediatrics The Hospital for Sick Children Toronto, Ontario, Canada.
³ Department of Pediatrics University of Toronto Toronto, Ontario, Canada.

Editorial

Valerie Waters. Am J Respir Crit Care Med. 2021.

. 2021 Dec 1;204(11):1245-1247.

doi: 10.1164/rccm.202108-1939ED.

Valerie Waters^{1

2

3}

¹ Research Institute The Hospital for Sick Children Toronto, Ontario, Canada.
² Department of Pediatrics The Hospital for Sick Children Toronto, Ontario, Canada.
³ Department of Pediatrics University of Toronto Toronto, Ontario, Canada.

No abstract available

Comment on

A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.
Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA; STOP2 Investigators. Goss CH, et al. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC. Am J Respir Crit Care Med. 2021. PMID: 34469706 Free PMC article. Clinical Trial.

1. Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, et al. STOP2 Investigators. A randomized trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment. Am J Respir Crit Care Med. 2021;204 - PMC - PubMed
1. McMullan BJ, Andresen D, Blyth CC, Avent ML, Bowen AC, Britton PN, et al. ANZPID-ASAP group. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infect Dis . 2016;204:e139–e152. - PubMed
1. Smith BJ, Heriot G, Buising K. Antibiotic treatment of common infections: more evidence to support shorter durations. Curr Opin Infect Dis . 2020;204:433–440. - PubMed
1. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, et al. PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA . 2003;204:2588–2598. - PubMed
1. Waters VJ, Kidd TJ, Canton R, Ekkelenkamp MB, Johansen HK, LiPuma JJ, et al. Antimicrobial Resistance International Working Group in Cystic F. Reconciling antimicrobial susceptibility testing and clinical response in antimicrobial treatment of chronic cystic fibrosis lung infections. Clin Infect Dis . 2019;204:1812–1816. - PubMed